• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.3607 -0.4090 (-53.14%)
Official Closing Price Updated: 8:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,631,130
Open 0.3809
Bid (Size) 0.3700 (8,700)
Ask (Size) 0.3770 (800)
Prev. Close 0.7697
Today's Range 0.3416 - 0.3809
52wk Range 0.3416 - 19.20
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OSU Researchers Develop Nanomaterial That Eliminates Cancer Cells
March 06, 2026
Via Investor Brand Network
UCLA Researchers Develop Method to Fix Fuel Shortages in Cancer Immunotherapy
February 27, 2026
Via Investor Brand Network

Performance

YTD
-69.4%
-69.4%
1 Month
-62.2%
-62.2%
3 Month
-75.3%
-75.3%
6 Month
-77.5%
-77.5%
1 Year
-96.5%
-96.5%

More News

Read More
Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments
February 25, 2026
Via Investor Brand Network
Cancer Stress Protein Enables Tumors to Evade the Immune System
February 20, 2026
Via Investor Brand Network
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy
February 17, 2026
Via Investor Brand Network
Early Symptoms of Lung Cancer You Could Be Ignoring
February 12, 2026
Via Investor Brand Network
Scientists Discover Why Immunotherapy Frequently Fails
February 04, 2026
Via Investor Brand Network
Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies
February 05, 2026
Via Investor Brand Network
Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds
January 29, 2026
Via Investor Brand Network
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
January 28, 2026
Via Investor Brand Network
Scientists Develop Next-Gen Antibodies That Boost the Body’s Cancer Killing Cells
January 21, 2026
Via Investor Brand Network
Study Discovers Molecule of Gut Bacteria That Boosts Immunotherapy Response
January 20, 2026
Via Investor Brand Network
Cornell Researchers Develop Particles That Can Supercharge Immunotherapy
January 14, 2026
Via Investor Brand Network
Curious about the stocks that are showing activity after the closing bell on Monday? ↗
January 12, 2026
Via Chartmill
New ‘Nanozigzag’ Biomaterial Shows Potential in Revolutionizing Cancer Immunotherapy
January 09, 2026
Via Investor Brand Network
New Approach Could Increase Response Rates for Cancer Immunotherapy
December 23, 2025
Via Investor Brand Network
Novel Biomarker Could Predict Resistance to Immunotherapy, Study Finds
December 17, 2025
Via Investor Brand Network
Study Highlights Increasing Cases of Breast Cancer in Younger Women
December 12, 2025
Via Investor Brand Network
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
December 08, 2025
Via Investor Brand Network
News headline image
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
December 05, 2025
Via ACCESS Newswire
Cancer Immunotherapy Could Be Boosted by Targeting Pathways of DNA Repair
December 04, 2025
Via Investor Brand Network
What Patients Need to Know About Exercising During Cancer Treatment
November 21, 2025
Via Investor Brand Network
Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer
November 19, 2025
Via Investor Brand Network
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
November 13, 2025
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 07, 2025
Via Benzinga

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 0.3607
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 03/06/26 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 2.59M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap